RA
GUTS icon

Rosalind Advisors’s Fractyl Health GUTS Stock Holding History

Rosalind Advisors’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-385,731
Closed -$849K – 49
2025
Q4 		$849K Sell
385,731
-4,614,269
-92% -$7.43M 0.3% 33
2025
Q3 		$7.95M Buy
+5,000,000
New +$6.49M 2.72% 17

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rosalind Advisors's GUTS Position: Q1 2026 in Review

Rosalind Advisors sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 385,731 shares — an estimated $849K sold.

Rosalind Advisors first reported a position in GUTS in Q3 2025 and held it in 2 quarters. The position peaked at $7.95M in Q3 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Rosalind Advisors reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
  • Rosalind Advisors sold 385,731 Fractyl Health shares in Q1 2026, an estimated $849K.
  • Rosalind Advisors first reported a position in Fractyl Health in Q3 2025 and held it in 2 quarters.
  • Rosalind Advisors's Fractyl Health position peaked at $7.95M in Q3 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Rosalind Advisors's 13F filing for Q1 2026, filed 14 May 2026.